透表和营解毒方治疗血热型银屑病的临床研究

黄港; 龚丽萍; 邱桂荣; 胡初向

透表和营解毒方治疗血热型银屑病的临床研究

黄港^1,2,
龚丽萍^1,2,
邱桂荣^1,2,
胡初向¹

1.
江西中医药大学皮肤病研究所，江西南昌 330006
2.
江西中医药大学附属医院，江西南昌 330006

计量
- 文章访问数: 650
- HTML全文浏览量: 8
- PDF下载量: 508
- 被引次数: 0
出版历程
- 刊出日期: 2019-07-10

Clinical Study on Treatment of Blood-Heat Psoriasis with Toubiao Heying Jiedu Recipe

1.
Institute of Dermatology, Jiangxi University of Traditional Chinese Medicine, Nanchang, 330006, China
2.
Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, 330006, China

摘要

摘要: 目的观察透表和营解毒方治疗血热型银屑病患者的临床疗效，及对血清IL-23/Th17轴相关细胞因子表达水平的影响。方法入组60例血热型银屑病患者和15名健康对照组。治疗组和对照组各为30例，分别予中药透表和营解毒方、阿维A胶囊口服治疗，以PASI积分评定疗效，观察健康人及银屑病患者治疗前后PASI积分、中医证候积分的变化及血清白细胞介素-17A（IL-17A）、白细胞介素-17F（IL-17F）、白细胞介素-26（IL-26）表达水平。结果血热型银屑病患者血清中IL-17A、IL-17F、IL-26水平显著高于健康人，差异具有显著统计学意义（P＜0.01），治疗后均明显下降（P<0.01）;治疗组优于对照组（P<0.01）。2组患者经治疗后PASI积分、中医证候积分较治疗前均下降（P＜0.01），治疗组优于对照组（P＜0.05~0.01）。2组治疗后不良反应发生率有显著性差异（P＜0.01）。结论银屑病的发生及病情严重程度与IL-23/Th17轴相关细胞因子的高表达有关；透表和营解毒方治疗血热型银屑病疗效确切，可能是通过调节IL-23/Th17轴相关因子水平而发挥治疗作用。
- IL-23/Th17轴 /
- 血热型银屑病 /
- 透表和营解毒方
Abstract: OBJECTIVE To observe the clinical effect of Toubiao Heying Jiedu recipe on patients with blood-heat psoriasis and its effect on the expression level of IL-23/Th17 axis-related cytokines in serum， so as to explore its mechanism of action. METHODS 60 patients with blood-heat psoriasis and 15 healthy controls were enrolled in the study. 30 cases in the treatment group and 30 cases in the control group were treated by oral administration of traditional Chinese medicine(TCM)， Toubiao Heying Jiedu recipe and avia A capsule respectively. The therapeutic effect was evaluated by PASI score， the level of IL-17A， IL-17F and IL-26 in serum of healthy people and psoriasis patients before and after treatment and the TCM score changes were observed. RESULTS The levels of IL-17A， IL-17F and IL-26 in serum of patients with blood-heat psoriasis were significantly higher than those of healthy people， and the difference was statistically significant(P<0.01). After treatment， the levels of IL-17A， IL-17F and IL-26 were significantly decreased (P<0.01). The treatment group was better than the control group (P<0.01). After treatment， PASI scores and TCM syndrome scores of the two groups were decreased (P<0.01). Moreover， the decrease in the treatment group was more obvious than that in the control group， and the difference was statistically significant (P<0.05， P<0.01). There was a significant difference in the incidence of adverse reactions between the two groups after treatment (P<0.01). CONCLUSION The occurrence and severity of psoriasis are related to the high expression of IL-23/Th17 axis related cytokines. Toubiao Heying Jiedu recipe have definite therapeutic effect on blood-heat psoriasis， which may play a therapeutic role by adjusting the level of IL-23/Th17 axis related factors.
- IL-23/Th17 axis /
- blood-heat psoriasis /
- Toubiao Heying Jiedu recipe

HTML全文

参考文献(13)

[1]	王明星，王燕，赵京霞，等.银屑病发病机制研究进展[J].辽宁中医杂志，2017，44(6):1334-1338.
[2]	CHEUK S，WIKEN M，BLOMQVIST L，et al.Epidermal TH22 and Tc17 cells form a localized disease memory in clinically healed psoriasis[J].J Immunol，2014，192(7):3111-3120.
[3]	赵辨．中国临床皮肤病学（下册)[M].4版.南京：江苏科学技术出版社，2010:1008-1025.
[4]	中华中医药学会皮肤科分会，北京中医药学会皮肤病专业委员会，北京中西医结合学会皮肤性病专业委员会.寻常型银屑病（白疕）中医药循证临床实践指南（2013版）[J].中医杂志，2014，55(1):76-82.
[5]	HACC D，SUNDSTROM A，ERIKSSON M，et al.Severity of psoriasis differs between men and women:a study of the clinical outcome measure psoriasis area and severity Index(PASI)in 5438 Swedishregister patients[J].Am J Clin Dermatol，2017，18(4):583-590.
[6]	BLAUVELT A. T-helper 17 cells in psoriatie plaques and additional genetic links between IL-23 and psoriasis[J]. J Invest Dermatol，2008， 128(5):1064-1067.
[7]	GANGULY D， HAAK S， SISIMK V， et al.The role of dendritic cells in utoimmunity[J]. Nat Rev Immunol，2013，13(8):566-577.
[8]	CHEN Z， TATO CM， MUUL L， et al. Distinct regulation of interleukin-17 in human T helper lymphocytes[J]. Arthritis Rheum， 2007，56(9):2936-2946.
[9]	TIAN H L，HOU YZ，WANG RY， et al．Physiological and pathological significance of IL-23 and its signaling pathways[J]. Immunol J， 2014，30(6):555-559．
[10]	WU HZ， WEI M， XU HJ， et al．New advances drugs targeting the IL-23/IL-17 axis for treatment of ankylosing spondylitis[J]. Chin J Rheumatol，2016，20(9):636-639．
[11]	冯素英．维甲酸类药[M].北京:人民卫生出版社，2004:537-549．
[12]	王建茹，唐雪勇，杨志波，等.刍议汗法与寻常型银屑病治疗[J].中医杂志，2014，55(5):444-445，448.
[13]	赵怀智，袁俊英，段彦娟，等.传统辨证基础上加辛温解表药治疗寻常型银屑病疗效观察[J].广西中医药，2017，40(3)：10-12.